Concepedia

Hooman Beygi

HB

3

Publications

69

Citations

3

H-Index

2013

Active since

Affiliations

Teva Pharmaceuticals (United States)(Current)

Hooman Beygi is an author at Teva Pharmaceuticals (United States) specializing in hematology, medicine, and iga glomerulonephritis.

Top concepts

Publications per year

2013–2018

3

Publications

3

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects

Frank Schneider, Lavi Erisson, Hooman Beygi et al. · British Journal of Clinical Pharmacology · 2018 · 39 citations · Full text

The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis

Beth Nordstrom, Kevin Knopf, Dana Y. Teltsch et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 17 citations

, , +22

Therapeutic Advances in Hematology

Kathryn S. Kolibaba, James A. Sterchele, Avani Joshi et al. · 2013 · 13 citations

, , +4

Rows per page

1–3 of 3